Project Grant HT94252510249
Award Date
8/1/25
Completion Date
7/31/27
Dollars Obligated
$467K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
University City, MO 63130, USA
Similar Awards
The Department of Defense's Defense Health Agency awarded a $1,127,375 Project Grant to The Washington University Office of Sponsored Research Services Division under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from Sep 30, 2023 to Sep 29, 2027, will fund research on "REPLICATION DRIVEN VULNERABILITIES IN CYCLIN E OVEREXPRESSING OVARIAN CANCERS". As a prominent research institution with expertise in biomedical sciences, The Washington...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $311,000.00 in funding to The Washington University in University City, Missouri. The award supports a 2-year research project using biomedical informatics and artificial intelligence to improve detection of degenerative cervical myelopathy, a neurological disorder. As a prominent private research university, The Washington University has extensive...
The Department of Defense's Defense Health Agency awarded a $155,500 Project Grant to The Washington University's Office of Sponsored Research Services Division to support a research project titled "ACTIVATION OF AN IMMUNE EVASION-TO-IMMUNE RECOGNITION SWITCH THROUGH THE INDUCTION OF IRF3 SIGNALING IN CRPCS". The grant, funded through the Military Medical Research and Development program (CFDA 12.420), will be executed over a 2-year period from May 1, 2024 to April 30, 2026. The...
The federal Project Grant award, valued at $250,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Washington University's Office of Sponsored Research Services Division. The award will fund a study on the "SUBCLINICAL PATHOPHYSIOLOGY OF MOTOR PROCESSING IN PEOPLE WITH MULTIPLE SCLEROSIS" over a 2-year period from September 30, 2024 to September 29, 2026. As a prominent private research university, The...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
This $437,544 Project Grant award was made on September 30, 2023 by the Defense Health Agency under the CFDA 12.420 Military Medical Research and Development program. The grant supports research at The Washington University in St. Louis, Missouri to study the phosphorylation tau profile of veterans with traumatic brain injury (TBI). The 3-year research project aims to improve understanding of neurological conditions affecting military service members and veterans. As a prominent private research...
This $899,273 federal Project Grant award was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research to transform healthcare for military service members and the broader public, with a focus on cancer research, neuroscience, genetic disorders, and emerging medical technologies. The lead awardee is The Washington University in St. Louis, which will conduct a multi-site study on precision...
The Washington University in St. Louis School of Medicine was awarded a $933,911 project grant from the Department of the Army Medical Command on September 30, 2022. The grant is part of the Military Medical Research and Development program (CFDA 12.420) and will support basic, applied, and advanced biomedical research efforts through September 29, 2025. Specifically, the grant funding will enable research to transform healthcare for service members and the general public through innovative...
The Washington University will receive $1,260,000 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on mutagenic deaminase activity in cancer from September 2021 through September 2025. Through this four-year project grant award, The Washington University researchers in University City, Missouri will investigate mutagenic deaminase activity and its relationship to cancer development and...
The federal Project Grant award of $932,918 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research at the University of Washington to determine the role of somatic mosaicism in ovarian cancer predisposition. The grant, awarded on September 30, 2024 with an ultimate completion date of September 29, 2028, will enable the University of Washington to conduct innovative scientific studies to improve health outcomes for military...